Search hospitals
>
South Carolina
>
Spartanburg
Spartanburg Medical Center
Claim this profile
Spartanburg, South Carolina 29303
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Breast cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Ovarian Cancer
319 reported clinical trials
15 medical researchers
Summary
Spartanburg Medical Center is a medical facility located in Spartanburg, South Carolina. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Non-Small Cell Lung Cancer, Ovarian Cancer and other specialties. Spartanburg Medical Center is involved with conducting 319 clinical trials across 437 conditions. There are 15 research doctors associated with this hospital, such as Michael Humeniuk, Amarinthia (Amy) Curtis, Vikas Dembla, and Jeremy M. Kilburn.
Area of expertise
Breast Cancer
Spartanburg Medical Center has run 65 trials for Breast Cancer. Some of their research focus areas include:
Lung Cancer
Spartanburg Medical Center has run 52 trials for Lung Cancer. Some of their research focus areas include:
Top PIs
Michael Humeniuk
Spartanburg Medical Center
9 years of reported clinical research
Amarinthia (Amy) Curtis
Spartanburg Medical Center
8 years of reported clinical research
Vikas Dembla
Spartanburg Medical Center
6 years of reported clinical research
Jeremy M. Kilburn
Gibbs Cancer Center-Pelham
6 years of reported clinical research
Clinical Trials running at Spartanburg Medical Center
Lung Cancer
Breast Cancer
Ovarian Cancer
Colorectal Cancer
Prostate Cancer
Bladder Cancer
Melanoma
Small Cell Lung Cancer
Non-Small Cell Lung Cancer
Pancreatic Cancer
High-Dose Radiation + Chemotherapy and Immunotherapy
for Non-Small Cell Lung Cancer
This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.
Recruiting
2 awards
Phase 3
14 criteria
Treatment Timing
for Non-Small Cell Lung Cancer
This phase III trial compares standard therapy given after surgery (adjuvant) to standard therapy given before and after surgery (perioperative) in treating patients with stage II-IIIB non-small cell lung cancer (NSCLC) that can be removed by surgery (resectable). The usual approach for patients with resectable NSCLC is chemotherapy and/or immunotherapy before surgery, after surgery, or both before and after surgery. This study is being done to find out which approach is better at treating patients with lung cancer. Treatment will be administered according to the current standard of care at the time of enrollment. Chemotherapy options may include cisplatin, carboplatin, pemetrexed, gemcitabine, docetaxel, and vinorelbine at standard doses according to the treating physician. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of tumor cells. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Pemetrexed is in a class of medications called antifolate antineoplastic agents. It works by stopping cells from using folic acid to make deoxyribonucleic acid (DNA) and may kill tumor cells. Gemcitabine is a chemotherapy drug that blocks the cells from making DNA and may kill tumor cells. Docetaxel is in a class of medications called taxanes. It stops tumor cells from growing and dividing and may kill them. Other chemotherapy drugs, such as vinorelbine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading . Immunotherapy with monoclonal antibodies, such as nivolumab, pembrolizumab, and atezolizumab, may help the body's immune system attack the tumor, and may interfere with the ability of tumor cells to grow and spread. Starting treatment with chemotherapy and immunotherapy prior to surgery and continuing treatment after surgery may be a more effective treatment option than adjuvant therapy alone in patients with stage II-IIIB resectable NSCLC.
Recruiting
2 awards
Phase 3
4 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting
2 awards
Phase 3
27 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Spartanburg Medical Center?
Spartanburg Medical Center is a medical facility located in Spartanburg, South Carolina. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Non-Small Cell Lung Cancer, Ovarian Cancer and other specialties. Spartanburg Medical Center is involved with conducting 319 clinical trials across 437 conditions. There are 15 research doctors associated with this hospital, such as Michael Humeniuk, Amarinthia (Amy) Curtis, Vikas Dembla, and Jeremy M. Kilburn.
Where is Spartanburg Medical Center located?
To reach Spartanburg Medical Center in Spartanburg, South Carolina, take I-26 to exit 22, head north on US-176/N Church St, and then turn right onto E Wood St. The hospital will be on your left. For real-time driving directions, consider using GPS navigation services like Waze.
Who should I call to ask about financial aid or insurance network?
**Spartanburg Medical Center Financial Assistance:** - To apply for financial assistance, request an application by calling **864-560-4123** or visit the website. Complete the form and return it as instructed. - Special circumstances affecting payment ability are reviewed by a Financial Counselor. Eligibility for free or discounted services is based on household income and family size. **Insurance Inquiries:** - For insurance questions, contact the Billing Department at **845-333-2455** or the Financial Advocate Office at **845-333-1888**. - Assistance includes financial aid applications, Medicaid applications, coverage verification, and payment coordination for procedures.
What insurance does Spartanburg Medical Center accept?
Spartanburg Medical Center accepts a wide range of insurance plans, including but not limited to Medicare Advantage, Aetna, BCBS, Cigna, and Humana. Oak Street Health Spartanburg is compatible with Original Medicare Part A and B, Medicare Supplement Insurance, and specific Medicare Advantage plans like Aetna Medicare Value Plus Plan and HumanaChoice. Additionally, the Spartanburg Regional Healthcare System has an agreement with UnitedHealthcare, offering in-network access for members with commercial and Medicare Advantage plans.
What awards or recognition has Spartanburg Medical Center received?
Spartanburg Medical Center is recognized as a Best Regional Hospital for the Upstate by U.S. News & World Report, excelling in nine procedures and conditions. It has been conducting clinical trials since 1990 through Spartanburg Medical Research, focusing on Phase I-III studies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.